Washington, DC 20006-5349
HELPLINE
The legal panel was moderated by Cheryl Bruner, Esq.The panel included:Joseph Belluck, Esq., Belluck & Fox, LLPDawn Besserman, Esq., MHRFMKathy Farinas, Esq., Dean Omar Branham Shirley, LLP This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous…
Mesothelioma is a cancer that affects a small amount of people who are exposed to asbestos. Why do some people develop mesothelioma and others do not? There is a genetic predisposition called BAP 1 germline mutation. Individuals who are BAP 1 positive have higher likelihood to develop different forms of…
Many patients and caregivers want to learn more about the diagnosis, looking to research studies and other data, but these studies are scientific and sometimes hard to read and understand. This session discusses how to read and understand data and studies. This session is presented by:Daniel Sterman, MD, New York University…
The Mesothelioma Applied Research Foundation is seeking participants for a study focused on understanding the experiences and challenges of caregivers of mesothelioma patients. The study, which is led by researchers at Michigan State University, will first conduct individual interviews and focus groups with caregivers of mesothelioma patients, with patients, and with those who have…
Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different clinical trial areas: immune checkpoint blockades, targeted therapies, anti-angiogenesis, and viral and neoantigen therapies. These sessions are presented by:Marjorie Zauderer, MD, Westchester Medical CenterMelina Marmarelis, MD,…
Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC). This session is presented by:Jason Foster, MD, University of NebraskaTravis Grotz, MD, Mayo Clinic This is a recording of a session at the 2024 International Symposium on Malignant…
A mesothelioma diagnosis and recurrence monitoring has many facets. Patients, when seeing their oncologists, may hear information about imaging, biopsies, pathology, and biomarkers and genetic analysis. These sessions will focus on each of these areas. These sessions are presented by:Christopher Straus, MD, University of ChicagoAndrea Wolf, MD, Mount SinaiJennifer Sauter, MD,…
These sessions showcase case studies over dual compartment disease and immunotherapy vs. chemotherapy. These sessions are presented by:R. Taylor Ripley, MD, Baylor College of MedicineManish Patel, DO, University of Minnesota This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by…
Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option for some patients. This session is presented by:Chuong Hoang, MD, National Cancer Institute This is a recording of a session at the 2024 International Symposium on…
Mesothelioma treatments are diverse. When a patient sees their oncologist, they may hear differing treatment options. These sessions focus on the different tools for treatment such as: chemotherapy, immunotherapy, combination therapies, and radiotherapy. These sessions are presented by:Hedy Kindler, MD, University of ChicagoKeith Cengel, MD, PhD, University of Pennsylvania This is…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
